6 haploidentical mesenchymal stem cells,” Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. [27] S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. [28] S. Mishima, A. Nagai, S. Abdullah et al., “Eﬀective ex vivo expansion of hematopoietic stem cells using osteoblast- diﬀerentiated mesenchymal stem cells is CXCL12 dependent,” European Journal of Haematology, vol. 84, no. 6, pp. 538–546, 2010. [29] J. Zhang and L. Li, “Stem cell niche: microenvironment and beyond,” Journal of Biological Chemistry, vol. 283, no. 15, pp. 9499–9503, 2008. [30] M. L. Burness and D. A. Sipkins, “The stem cell niche in health and malignancy,” Seminars in Cancer Biology, vol. 20, no. 2, pp. 107–115, 2010. [31] B. S. Lam and G. B. Adams, “Hematopoietic stem cell lodg- ment in the adult bone marrow stem cell niche,” International Journal of Laboratory Hematology, vol. 32, no. 6, pp. 551–558, 2010. [32] J. M. Burns, B. C. Summers, Y. Wang et al., “A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development,” Journal of Experimental Medicine, vol. 203, no. 9, pp. 2201–2213, 2006. [33] P. T. Thevenot, A. M. Nair, J. Shen, P. Lotﬁ, C. Y. Ko, and L. Tang, “The eﬀect of incorporation of SDF-1α into PLGA scaﬀolds on stem cell recruitment and the inﬂammatory response,” Biomaterials, vol. 31, no. 14, pp. 3997–4008, 2010. [34] I. Rappold, S. M. Watt, N. Kusadasi, S. Rose-John, J. Hatzfeld, and R. E. Ploemacher, “Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors,” Leukemia, vol. 13, no. 12, pp. 2036–2048, 1999. [35] J. Y. Han, R. Y. Goh, S. Y. Seo et al., “Cotransplantation of cord blood hematopoietic stem cells and culture-expanded and GM-CSF-/SCF-transfected mesenchymal stem cells in SCID mice,” Journal of Korean Medical Science, vol. 22, no. 2, pp. 242–247, 2007. [36] A. Bernstein, L. Forrester, A. D. Reith, P. Dubreuil, and R. Rottapel, “The murine W/c-kit and steel loci and the control of hematopoiesis,” Seminars in Hematology, vol. 28, no. 2, pp. 138–142, 1991. [37] M. Verfaillie, “Adhesion receptors as regulators of the hematopoietic process,” Blood, vol. 92, no. 8, pp. 2609–2612, 1998. [38] R. Schoﬁeld, “The relationship between the spleen colony- forming cell and the haemopoietic stem cell,” Blood Cells, vol. 4, no. 1-2, pp. 7–25, 1978. [39] R. W. Garrett and S. G. Emerson, “Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches,” Cell Stem Cell, vol. 105, no. 4, pp. 503–506, 2009. [40] E. Fuchs, T. Tumbar, and G. Guasch, “Socializing with the neighbors: stem cells and their niche,” Cell, vol. 116, no. 6, pp. 769–778, 2004. [41] F. Fierro, T. Illmer, D. Jing et al., “Inhibition of platelet-derived growth factor receptor-β by imatinib mesylate suppresses pro- liferation and alters diﬀerentiation of human mesenchymal stem cells in vitro,” Cell Proliferation, vol. 40, no. 3, pp. 355– 366, 2007. [42] B. Sacchetti, A. Funari, S. Michienzi et al., “Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment,” Cell, vol. 131, no. 2, pp. 324–336, 2007. Bone Marrow Research [43] M. J. Kiel, O. H. Yilmaz, T. Iwashita, O. H. Yilmaz, C. Terhorst, and S. J. Morrison, “SLAM family receptors dis- tinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells,” Cell, vol. 121, no. 7, pp. 1109–1121, 2005. [44] T. Yin and L. Li, “The stem cell niches in bone,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1195–1201, 2006. [45] M. H. Raaijmakers, “Regulating traﬃc in the hematopoietic stem cell niche,” Haematologica, vol. 95, no. 9, pp. 1439–1441, 2010. [46] B. Heissig, K. Hattori, S. Dias et al., “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand,” Cell, vol. 109, no. 5, pp. 625– 637, 2002. [47] F. Arai, A. Hirao, M. Ohmura et al., “Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche,” Cell, vol. 118, no. 2, pp. 149–161, 2004. [48] Y. Xie, T. Yin, W. Wiegraebe et al., “Detection of functional haematopoietic stem cell niche using real-time imaging,” Nature, vol. 457, no. 7225, pp. 97–101, 2009. [49] R. S. Taichman and S. G. Emerson, “The role of osteoblasts in the hematopoietic microenvironment,” Stem Cells, vol. 16, no. 1, pp. 7–15, 1998. [50] Y. Muguruma, T. Yahata, H. Miyatake et al., “Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment,” Blood, vol. 107, no. 5, pp. 1878– 1887, 2006. [51] S. Me´ndez-Ferrer, T. V. Michurina, F. Ferraro et al., “Mes- enchymal and haematopoietic stem cells form a unique bone marrow niche,” Nature, vol. 466, no. 12, pp. 829–834, 2010. [52] M. K. Majumdar, M. A. Thiede, S. E. Haynesworth, S. P. Bruder, and S. L. Gerson, “Human marrow-derived mes- enchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when diﬀerentiated toward stromal and osteogenic lineages,” Journal of Hema- totherapy and Stem Cell Research, vol. 9, no. 6, pp. 841–848, 2000. [53] L. Shi and L. H. Hu, “The normal ﬂora may contribute to the quantitative preponderance of myeloid cells under physiological conditions,” Medical Hypotheses, vol. 21, no. 12, pp. 141–143, 2011. [54] K. S. Jeltsch, T. F. Radke, S. Laufs et al., “Unrestricted somatic stem cells: interaction with CD34+ cells in vitro and in vivo, expression of homing genes and exclusion of tumorigenic potential,” Cytotherapy, vol. 13, no. 3, pp. 357–365, 2011. [55] B. B. Ratliﬀ, N. Singh, K. Yasuda et al., “Mesenchymal stem cells, used as bait, disclose tissue binding sites,” American Journal of Pathology, vol. 177, no. 2, pp. 873–883, 2010. [56] J. Y. Ahn, G. Park, J. S. Shim, J. W. Lee, and I. H. Oh, “Intramarrow injection of β-catenin-activated, but not na¨ıve mesenchymal stromal cells stimulates self-renewal of hematopoietic stem cells in bone marrow,” Experimental and Molecular Medicine, vol. 42, no. 2, pp. 122–131, 2010. [57] M. Tavassoli and A. Friedenstein, “Hemopoietic stromal microenvironment,” American Journal of Hematology, vol. 15, no. 2, pp. 195–203, 1983. [58] P. A. Marks, V. M. Richon, and R. A. Rifkind, “Histone deacetylase inhibitors: inducers of diﬀerentiation or apoptosis of transformed cells,” Journal of the National Cancer Institute, vol. 92, no. 15, pp. 1210–1216, 2000. [59] A. P. Wolﬀe, P. L. Jones, and P. A. Wade, “DNA demethylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 5894–5896, 1999.